Article info

other Versions

PDF
Randomised controlled trial
Aspirin given for up to 2 years after initial anticoagulant treatment reduces the risk of venous thromboembolism recurrence without increasing risk of major bleeding

Authors

  1. Correspondence to : Dr Henry G Watson
    Department of Haematology, Aberdeen Royal Infirmary, Foresterhill Health Campus, Aberdeen AB25 2ZN, UK; henrywatson{at}nhs.net
View Full Text

Citation

Watson HG
Aspirin given for up to 2 years after initial anticoagulant treatment reduces the risk of venous thromboembolism recurrence without increasing risk of major bleeding

Publication history

  • Published in print 1 November 2012.
  • Published online 23 November 2012.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.